The Global Politics of Human Embryonic Stem Cell Science : Regenerative Medicine in Transition

Regenerative medicine is a field characterized by a global struggle for scientific, economic and national advantage. Drawing on a wide range of interviews, primary and secondary sources, this book investigates the dynamic interactions between national regulatory formation and the global biopolitics of regenerative medicine and human embryonic stem cell science. Today governments are under intense competitive pressure to fund and develop attractive national environments for embryonic stem cell science, which promises both to improve the health and productivity of aging populations and to develop therapies for global health markets. This study traces the development of internationally circulating arguments for and against stem cell research, and the various transnational bioethical spaces that have opened up to try and steer these arguments towards compromise and implementation. It considers the flow of embryonic and reproductive biological materials from south to north, and the ways these flows play into broader relations around global biopolitics. It investigates the place of transnational regulatory bodies like the EU and the UN in organizing and modifying the international and national debates around stem cell science, and ways in which national debates and policies influence each other. It makes a major contribution to our understanding of the dynamics of power that fuels the emergence of global regenerative medicine in the age of biotechnology NL-ZmNBD Contents......Page 6 List of Tables......Page 7 Acknowledgements......Page 8 Series Editors’ Preface......Page 9 Introduction: Stem Cell Research and Global Biopolitics......Page 12 1 Globalization, Stem Cell Markets and National Interests......Page 33 2 Embryos, Oocytes, Cell Lines: HESC Science and the Human Tissue Market......Page 46 3 Global Regulation and Local Policy Narratives: Making Sense of Dolly......Page 67 4 From Dolly to Therapies? Stem Cell Regulations in the Making I – The United Kingdom and the United States......Page 97 5 From Dolly to Therapies? Stem Cell Regulations in the Making II – Germany, Italy, Japan and South Korea......Page 116 6 Bioethics and the Global Moral Economy of HESC Science......Page 138 7 HESC Science and the Cultural Politics of the EU’s Framework Programmes......Page 159 8 Contested Governance: Uncertainty and Standardization in Research and Patenting......Page 180 Conclusions: Towards the Global Politics of Stem Cell Research......Page 198 Notes......Page 206 References......Page 209 C......Page 231 G......Page 232 J......Page 233 P......Page 234 S......Page 235 Z......Page 236 Investigating The Global Biopolitical Relations Between The Commercial And Scientific Trajectory Of Stem Cell Research, This Title Explores The Contentious Ethical Status Of Embryos And Stem Cells. Globalization, Stem Cell Markets And National Interests -- Embryos, Ocytes, Cell Lines : Hesc Science And The Human Tissue Market -- Global Regulation And Local Policy Narratives : Making Sense Of Dolly -- From Dolly To Therapies : Stem Cell Regulations In The Making I : The United Kingdom And The United States -- From Dolly To Therapies : Stem Cell Regulations In The Making Ii : Germany, Italy, Japan, And South Korea -- Bioethics And The Global Moral Economy Of Human Embryonic Stem Cell Science -- Human Esc Science And The Cultural Politics Of The Eu's Framework Programmes -- Contested Governance : Uncertainty And Standardization In Research And Patenting. By Herbert Gottweis, Brian Salter And Catherine Waldby. Includes Bibliographical References (p. 198-219) And Index. Drawing on a wide range of interviews and primary and secondary sources, this book investigates the dynamic interactions between national regulatory formation and the global biopolitics of regenerative medicine and human embryonic stem cell science.